40: A Shot at Love with Nonprofit Insulin
Jan 21, 2026•29 min•Ep. 40
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Nonprofit pharmaceutical company Civica has released it's biosimilar version of Lantus long-acting insulin for $55 for a box of 5 pens—that's the list price it costs you to buy it without needing insurance, coupons, or patient assistance programs. We look at how a nonprofit business model can drastically lower prices for patients and governments.
-
More info about Civica insulin and CalRx Insulin
-
CalRx Patient Advisory Council Charter
-
Episode on insulin pricing
-
Episode on co-pay cap laws
-
119th Congress pro-healthcare scorecard
Support Beta Cell on Patreon.
For the best experience, listen in Metacast app for iOS or Android